INKT ▲ +1.5% - MiNK Therapeutics, Inc. $INKT - MiNK Therapeutics New Data Highlights Its Off-the-Shelf iNKT Cell Therapy Targets Two Key Mechanisms of Tumor Resistance Presented at the Society of Immunotherapy of Cancer (SITC 2026) 06-NOV-2026 09:48 AM ET